Coverage
-
September 09, 2013
Generic-drug maker Sandoz Inc. on Monday agreed not to make, sell or distribute a version of Merck & Co. Inc.'s anti-cholesterol drug Zetia until 2017, putting to rest Merck's patent infringement suit.
1 other articles on this case.
View all »